Toxicology Reports (Jan 2022)

Evaluation of acute and sub-acute toxicity profile of 5-methylcoumarin-4β-glucoside in mice

  • Bilyaminu Abubakar,
  • Alhassan Muhammad Alhassan,
  • Ibrahim Malami,
  • Dawoud Usman,
  • Yaaqub Abiodun Uthman,
  • Kehinde Ahmad Adeshina,
  • Mutolib Olabayo Olatubosun,
  • Mustapha Umar Imam

Journal volume & issue
Vol. 9
pp. 366 – 372

Abstract

Read online

Vernonia glaberrima leaves are traditionally used to alleviate bodily pain, skin cancer, and other skin-related disorders. The purpose of the study was to investigate the acute and sub-acute toxicity of 5-methylcoumarin-4β-glucoside, a promising chemotherapeutic agent against colon cancer isolated from the leaves of Vernonia glaberrima. 5-methylcoumarin-4β-glucoside was isolated from the methanol leaf extract of Vernonia glaberrima following a previously described method. The acute toxicity study involved a two-phase 24 h observation for signs of mortality and toxicity following single oral dose administration of the isolated compound. For the sub-acute study, four groups of mice, averagely aged eight weeks, were administered graded doses of the compound (250, 500 and 1000 mg/kg) or vehicle for 28 days. On the 29th day, the mice were fasted, anesthetized, euthanized, then their blood and tissues were harvested for hematological, biochemical and histopathological evaluations. There were no signs of mortality or moribund status with an increasing dose of up to 5000 mg/kg over a 24 h period in the acute study. Also, there was no evidence of toxicity on the biochemical or hematopoietic systems in the sub-acute study (p < 0.05). At the dose of 1000 mg/kg, the mice showed some distorted histology with no corresponding alterations in serum biochemicals. Overall, the results showed that 5-methylcoumarin-4β-glucoside at dosages up to 500 mg/kg is tolerable in mice.

Keywords